Blueprint Medicines Email Format
Biotechnology ResearchMassachusetts, United States501-1000 Employees
Blueprint Medicines is a mid-sized biotechnology company based in Cambridge, Massachusetts, focused on discovering and developing medicines that address the root causes of disease in allergy/inflammation and oncology/hematology. As a fully integrated global biopharmaceutical company, it combines research, development, and commercialization capabilities to bring therapies to patients. The firm has two medicines approved in the United States and Europe and is advancing a broad pipeline in mast cell diseases, including systemic mastocytosis and chronic urticaria, as well as breast cancer and other solid tumors. Patients are central to its work, and the organization promotes a culture built on transparency, curiosity, and diversity, with employees referred to as the Blue Crew. It relies on its established research, development, and commercial infrastructure to pursue programs from early science through advanced clinical trials, aiming to broaden its impact across its core areas.